RxDoctor Payments Data

Daniel Popowitz

Foot & Ankle Surgery · New York, NYNPI 1942599741

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,350 of the $16,731 with a category attached, or 61.9%. 28 manufacturers reported payments, led by Ossio Inc at 35.8% of the total. Reporting peaked in 2021 at $6,435 and has fallen 68.9% since, to $1,999 in 2025. Among foot & ankle surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,731in general payments, 2019–2025

Across 85 payments — averaging $196.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ossio Inc$6K
  • Crossroads Extremity Systems, LLC$3K
  • Royal Biologics, Inc.$2K
  • Arthrex$1K
  • Gotham Surgical Solutions & Devices, Inc.$1K
  • Zimmer Biomet$736
  • plus $3K from 22 others
$50,000in ownership & investment interests, 2019–2025

Across 5 payments — averaging $10,000 each. An ownership or investment interest held by the physician or an immediate family member.

  • Ossio LTD$50K

What the payments were for

  • Consulting fees$10,35062%
  • Travel & lodging$4072%
  • Food & beverage$3,57421%
  • Education$2,40014%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,731 in reported general payments places this provider in the 90th percentile of 652 foot & ankle surgery providers in New York.

See all foot & ankle surgery providers in New York

Medicare billing

Part B allowed, 2024
$72,712
Medicare patients
225
Services billed
1,554

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium ErDiclofenac Sodium82$6,482
Naproxen Sodium18$2,513
Doxepin Hcl24$2,505
Ketoconazole12$293
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$73
Ibuprofen17$54
Cephalexin11$31

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →